Net loss for fiscal year 2025 was $66.5 million, a substantial increase from $6.0 million in 2024 and $12.1 million in 2023. Total revenue, net, increased by only 1% to $201.5 million in 2025, up from $200.5 million in 2024. Product revenue decreased by 6% to $144.2 million in 2025, while service revenue increased by 21% to $57.3 million. Gross margin declined to 52% in 2025 from 55% in 2024, primarily due to higher tariff costs and increased production overhead from transitioning a manufacturing facility overseas. General and administrative expenses surged by 37% to $58.9 million in 2025, mainly due to higher patent litigation expenses, compensation, sales and use tax, and software expenses. Research and development expenses decreased by 7% to $36.5 million, reflecting efforts to streamline and focus activities. Cash and cash equivalents, restricted cash, and short-term investments decreased to $261.5 million in 2025 from $277.9 million in 2024. The company repurchased 3,292,588 shares of common stock for approximately $15.1 million in 2025, with $35.0 million remaining authorized in the program. Material weaknesses in internal control over financial reporting identified in 2024 were remediated by December 31, 2025. The legal settlement liability with Becton, Dickinson and Company was reduced by $1.0 million in Q4 2025 due to a revised long-term sales forecast.